Device Trial Radar · NCT06622538
Orotracheal Intubation with the ORION Videolaryngoscope Versus the King Vision Videolaryngoscope in Adult Patients: ORION Trial
Last checked: Nov 20, 2026Latest source record: Feb 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Oct 1, 2024
Primary completion
Oct 15, 2024
Study completion Oct 31, 2024
Sponsor
- Lead sponsor
- Hospital General de México Dr. Eduardo LiceagaGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Oct 2, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study aims to compare the ORION video laryngoscope with the King Vision video laryngoscope for orotracheal intubation in patients without predictors of difficult airway scheduled for elective surgery under general anesthesia.
Conditions
- Orotracheal Intubation
- Videolaryngoscopes (VL)
- 3D Printing
- Anesthesia
Interventions
Orotracheal intubationDevice
Patients who meet the inclusion criteria and sign the informed consent form will be intubated with the ORION or King Vision video laryngoscope according to randomisation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Successful first attemptTime frame: After the endotracheal intubation completed
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital General de Mèxico Dr. Eduardo Liceaga
Mexico City, Cuauhtemoc, Mexico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.